Highbridge Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Highbridge Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$2.15M	–	453
2023 Q2	$2.06M	Buy	+20,000	New	+$2.11M	0.09%	105
2017 Q3	–	Sell	-276,472	Closed	-$3.28M	–	1915
2017 Q2	$3.28M	Sell	276,472 -1,268,697	-82%	-$15.8M	0.05%	370
2017 Q1	$22.8M	Buy	1,545,169 +967,927	+168%	+$15.7M	0.33%	76
2016 Q4	$9.34M	Buy	577,242 +184,051	+47%	+$3.34M	0.17%	163
2016 Q3	$7.13M	Sell	393,191 -384,280	-49%	-$7.51M	0.11%	204
2016 Q2	$12.8M	Sell	777,471 -712,769	-48%	-$11.5M	0.21%	135
2016 Q1	$24.7M	Sell	1,490,240 -160,876	-10%	-$2.81M	0.41%	59
2015 Q4	$35.8M	Buy	1,651,116 +1,595,364	+2,862%	+$31.1M	0.55%	31
2015 Q3	$1.1M	Buy	55,752 +29,648	+114%	+$937K	0.02%	736
2015 Q2	$907K	Sell	26,104 -355,133	-93%	-$10.8M	0.01%	756
2015 Q1	$9.9M	Buy	+381,237	New	+$6.99M	0.14%	201

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Highbridge Capital Management's HZNP Position: Q3 2023 in Review

Highbridge Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 20,000 shares — an estimated $2.15M sold.

Highbridge Capital Management first reported a position in HZNP in Q1 2015 and held it in 11 quarters. The position peaked at $35.8M in Q4 2015. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Highbridge Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Highbridge Capital Management sold 20,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $2.15M.
Highbridge Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 11 quarters.
Highbridge Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $35.8M in Q4 2015.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Highbridge Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.